A clinical formulation indicated for Antiparasitics. Promotes the eradication of parasitic organisms within the gastrointestinal tract to restore physiological intestinal health.
Indicated to address intestinal worm infections by targeting parasite muscular function to alleviate infestations and support gastrointestinal health in adult and pediatric patients.
Mechanism of Action
Levamisole paralyzes the muscles of the parasitic worms by acting on their nerves. Once paralyzed, the worms lose their grip on the intestinal wall and are naturally expelled from the body through bowel movements.
Route of Administration
Oral
Onset Time
Steady state in 2 hours
Duration
24–48 hours for expulsion
Contraindications
Severe liver or kidney disease, Blood disorders, Pregnancy
Severe Adverse Events
Agranulocytosis (Severe low white cells), Convulsions, Severe allergic reactions, Encephalopathy
Information for Dicaris is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
